Liberdade médica questionável
DOI:
https://doi.org/10.22481/rsc.v19i4.12876Resumo
Uma suposta liberdade ou autonomia médica foi o álibi para o uso de medicamentos inócuos e que envolveram riscos durante a pandemia de Covid-19 no Brasil. É importante discutir como isso ocorreu e quais as possíveis consequências. Também é fundamental atribuir responsabilidades em relação à essa atitude de parte da comunidade médica brasileira, e analisar como é possível reconhecer esse equívoco e desmistificar qualquer justificativa para esse processo. Finalmente é preciso perceber o papel do Conselho Federal de Medicina, no seu alinhamento político e ideológico, no suporte ao uso dessas drogas ineficazes de forma precoce contra o SARS-CoV-19.
Downloads
Referências
Silva HM. The (in) competence of the Bolsonaro government in confronting Covid-19. Infect Control Hosp Epidemiol 2021; : 1–3.2 Ricard J, Medeiros J. Using misinformation as a political weapon: COVID-19 and Bolsonaro in Brazil. Harvard Kennedy Sch Misinformation Rev 2020. doi:10.37016/mr-2020-013.3 Campos GW de S. O pesadelo macabro da Covid-19 no Brasil: entre negacionismos e desvarios. Trab Educ e Saúde 2020; 18.4 McKee M, Diethelm P. How the growth of denialism undermines public health. Bmj 2010; 341. doi:10.1136/bmj.c6950.5 Wankel C. Management education using social media. Organ Manag J 2009; 6: 251–262.6 Silva HM. The danger of denialism: lessons from the Brazilian pandemic. Bull Natl Res Cent 2021; 45: 55.7 Fonseca EM da, Nattrass N, Lazaro LLB, Bastos FI. Political discourse, denialism and leadership failure in Brazil’s response to COVID-19. Glob Public Health 2021; 16: 1251–1266.8 Guerreiro C, Almeida R de. Negacionismo religioso: Bolsonaro e lideranças evangélicas na pandemia Covid-19. Reli Soc 2021; 41: 49–74.9 Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G et al. COVID-19: towards controlling of a pandemic. Lancet 2020; 395: 1015–1018.10 Silva HM. Medicines and Illusions in the fight against COVID-19 in Brazil. Ethics, Med Public Heal 2021; 16: 100622.11 Silva HM. Tratamento profilático contra a Covid-19 no Brasil, um risco inútil. Rev Saúde com 2022; 18.12 Silva HM. O Principal Remédio de Combate À Covid-19 No Brasil: Uma Ilusão Médica. Rev Port Ciências e Saúde 2022; 3: 45–54.13 Furlan L, Caramelli B. The regrettable story of the “Covid Kit” and the “Early Treatment of Covid-19” in Brazil. Lancet Reg Heal 2021; 4.14 Sutherland IH. Veterinary use of ivermectin. Acta Leiden 1990; 59: 211–216.15 White NJ, Miller KD, Churchill FC, Berry C, Brown J, Williams SB et al. Chloroqine treatment of severe malaria in children. N Engl J Med 1988; 319: 1493–1500.16 Silva HM. Antibiotics against viruses: Brazilian doctors adrift. Infect Control Hosp Epidemiol 2021; : 1–5.17 Chen Y, Shen T, Zhong L, Liu Z, Dong X, Huang T et al. Research progress of chloroquine and hydroxychloroquine on the COVID-19 and their potential risks in clinic use. Front Pharmacol 2020; 11: 1167.18 Orso D, Federici N, Copetti R, Vetrugno L, Bove T. Infodemic and the spread of fake news in the COVID-19-era. Eur J Emerg Med 2020.19 Ferner R, Pucci M. Adverse drug reactions. Medicine (Baltimore) 2020; 48: 443–449.20 Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S et al. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med 2021; 9: 407–418.21 Silva HM. A sad example of the destructive potential of Brazilian science denialism. Rev Científic@ Univ2023; 10: 15–31.22 Xavier DR, e Silva EL, Lara FA, e Silva GRR, Oliveira MF, Gurgel H et al. Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study. Lancet Reg Heal 2022; : 100221.23 Wise J. Covid-19: WHO declares end of global health emergency. BMJ 2023; : 1041.24 Jain S, Venkataraman A, Wechsler ME, Peppas NA. Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic. Adv Drug Deliv Rev 2021; 179: 114000.25 Lin D-Y, Xu Y, Gu Y, Zeng D, Sunny SK, Moore Z. Durability of bivalent boosters against omicron subvariants. N Engl J Med 2023; 388: 1818–1820.26 Curcio CH, Marian J. O DISCURSO INFODÊMICO EM TERRAS BRASILEIRAS À LUZ DA COVID-19. Cad PAIC 2021; 22: 9–36.27 Silva H. The historic success of vaccination and the global challenge posed by inaccurate knowledge in social networks. Patient Educ Couns 2021; : 213–214.28 Hellmann F, Homedes N. An unethical trial and the politicization of the COVID‐19 pandemic in Brazil: The case of Prevent Senior. Dev World Bioeth 2022.29 Santos-Pinto CDB, Miranda ES, Osorio-de-Castro CGS. O “kit-covid” e o Programa Farmácia Popular do Brasil. Cad Saude Publica 2021; 37: e00348020.30 de Ulysséa Leal D, da Silva Lopes I, Andrade MP. Quando o Governo desinforma: A COVID-19 e o Tratamento Precoce no Brasil. Razón y Palabra 2021; 25.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Revista Saúde.com
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
